Tim Waterboer Selected Research

Tim Waterboer Research Topics

Disease

70	Neoplasms (Cancer) 03/2022 - 03/2005
42	Infections 01/2022 - 10/2007
22	Papillomavirus Infections 03/2022 - 01/2008
20	Oropharyngeal Neoplasms 11/2022 - 04/2011
14	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2014
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 10/2005
13	Stomach Neoplasms (Stomach Cancer) 10/2021 - 11/2015
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 10/2007
10	Squamous Cell Carcinoma of Head and Neck 10/2021 - 04/2011
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 10/2012
6	Multiple Sclerosis 01/2022 - 02/2016
6	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 01/2008
5	Skin Neoplasms (Skin Cancer) 03/2022 - 11/2008
5	Anus Neoplasms (Anal Cancer) 01/2022 - 03/2015
5	Carcinogenesis 08/2019 - 02/2010
4	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2014
4	Nasopharyngeal Carcinoma 01/2022 - 11/2019
4	Epstein-Barr Virus Infections 12/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2011
3	Coinfection 03/2022 - 12/2020
3	Infectious Mononucleosis (Glandular Fever) 01/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2011
3	Persistent Infection 01/2019 - 01/2016
2	COVID-19 01/2022 - 01/2021
2	Uterine Cervical Dysplasia 01/2022 - 01/2022
2	Papilloma (Papillomatosis) 01/2022 - 02/2011
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Stomach Diseases 01/2021 - 10/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2013
2	Unknown Primary Neoplasms 01/2021 - 01/2018
2	Obesity 01/2021 - 01/2021
2	Condylomata Acuminata (Genital Wart) 01/2021 - 10/2009
2	Squamous Intraepithelial Lesions 11/2020 - 01/2010
2	Metrorrhagia (Spotting) 11/2020 - 02/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2019
2	Hepatitis B 01/2020 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 12/2019 - 12/2019
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2015
2	Herpes Simplex 11/2016 - 09/2012
2	Polyomavirus Infections 10/2016 - 02/2013
1	HIV Infections (HIV Infection) 03/2022
1	Hepatitis 01/2022
1	Reinfection 01/2022
1	Insulin Resistance 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

91	AntibodiesIBA 05/2022 - 10/2005
40	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2008
39	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2009
39	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 03/2005
30	AntigensIBA 01/2022 - 01/2015
12	ORALIT (ORS)IBA 01/2022 - 08/2012
10	Oncogene Proteins (Oncogene Protein)IBA 11/2022 - 10/2005
10	VaccinesIBA 10/2021 - 06/2007
8	Immunoglobulin G (IgG)IBA 01/2022 - 11/2016
6	ProteomeIBA 01/2021 - 01/2018
6	Capsid Proteins (Capsid Protein)IBA 01/2021 - 06/2007
5	Immunoglobulin A (IgA)IBA 01/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 11/2017 - 07/2014
4	EBV-encoded nuclear antigen 1IBA 12/2021 - 01/2020
4	Cytotoxins (Cytolysins)IBA 12/2021 - 06/2020
4	Biological ProductsIBA 10/2021 - 01/2008
4	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2018 - 10/2012
3	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2022 - 02/2011
3	Contraceptive Agents (Contraceptives)IBA 01/2022 - 01/2016
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 06/2020
3	Viral DNAIBA 01/2021 - 07/2015
3	AutoantibodiesIBA 01/2018 - 01/2016
2	ImmunosorbentsIBA 05/2022 - 02/2010
2	EnzymesIBA 05/2022 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 01/2016
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2021
2	Viral AntigensIBA 01/2020 - 10/2018
2	AnoctaminsIBA 01/2019 - 02/2016
2	FlagellinIBA 01/2019 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 10/2017 - 12/2009
2	Nucleic AcidsIBA 10/2016 - 01/2010
2	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2016 - 10/2012
2	CatalaseIBA 04/2016 - 12/2009
2	Rituximab (Mabthera)FDA Link 01/2016 - 10/2015
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2015 - 06/2007
1	Epstein-Barr virus early antigenIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	cytomegalovirus-specific hyperimmune globulinIBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	LipidsIBA 01/2022
1	Vitamin D FDA LinkGeneric 12/2021
1	Estrogen Receptor alphaIBA 10/2021
1	Eflornithine (Ornidyl)FDA Link 10/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2021

Therapy/Procedure

3	Therapeutics 01/2020 - 06/2010
2	Aftercare (After-Treatment) 01/2020 - 01/2017
2	Organ Transplantation 01/2015 - 02/2013
1	Chemoprevention 10/2021